Latest filing published 28 May 2015 for SKYSTAR BIO-PHARMACEUTICAL CO, €171k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
John M. Gregory has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Stellar Pharmaceuticals Inc, Adams Golf Inc and Skystar Bio-Pharmaceutical Co. Between 29 November 2007 and 26 May 2015, the trades on record add up to 26 filings.
No open-market sale appears; the market trades are 21 purchases worth €2.5M. The amount is not disclosed for 3 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants. Since January 2015: 4 purchases and no sales on the market.
In size, the median ticket on the buying side is €58k.
On 28 May 2015 came the latest disclosure, an open-market purchase for €171k in Skystar Bio-Pharmaceutical Co. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations